GO
Loading...

Massachusetts

More

  • Alzheimer drug shows some promise in mild disease Monday, 8 Oct 2012 | 1:33 PM ET

    Detailed results were revealed for the first time Monday at an American Neurological Association conference in Boston. "It's certainly not the home run we all wanted, but we're very encouraged by these results," said Maria Carillo, chief science officer for the Alzheimer's Association, which had no role in the research.

  • Lilly drug may help mild Alzheimer's - studies Monday, 8 Oct 2012 | 1:15 PM ET

    Oct 8- Eli Lilly and Co said pooled data from two large studies show patients with mild Alzheimer's disease taking its experimental drug solanezumab had 34- percent less decline in memory over 18 months compared with those taking placebos.

  • At a Glance: Weekly change in state gas prices Monday, 8 Oct 2012 | 1:14 PM ET
  • The widening outbreak has alarmed federal and state health officials and focused attention on regulation of pharmaceutical compounding companies like the one that produced the drugs, the New England Compounding Center Inc in Framingham, Massachusetts.

  • Bourbon tourism: New visitors center at Jim Beam Monday, 8 Oct 2012 | 11:47 AM ET

    CLERMONT, Ky.-- Bourbon fan Tim Allen started his day of sightseeing by sipping whiskeys crafted at a Jim Beam distillery. Where else are pre-lunch nips more commonplace than in Kentucky bourbon country?

  • --U.S. women's specialty apparel retailer Jill Holdings LLC amended financial covenants under its existing term loan. --We are also raising the issue-level rating on subsidiary JJ Lease Funding Corp.' s $120 million term loan B to' B-' from' CCC' and revising the recovery rating to' 3' from' 4'.

  • *Romney claws his way back after first debate* Only 2 points behind in Reuters/ Ipsos poll By Steve Holland. PORT ST. LUCIE, Fla., Oct 7- Mitt Romney appeared on Sunday to have halted his perilous slide in the polls and is back to running a close race with President Barack Obama as he prepares a new assault on the Democrat over foreign policy.

  • Soda industry: Vending machines will show calories Monday, 8 Oct 2012 | 10:08 AM ET

    "They're seeing the writing on the wall and want to say that it's corporate responsibility," said Mike Jacobson, executive director of the Center for Science in the Public Interest, which advocates for food safety and nutrition.

  • BOSTON, Oct 8- There are distinctive ways that you can boost what you bring to your organization- and they don't involve the usual kissing up to your boss, says Harvard Business Review. The Management Tip of the Day offers quick, practical management tips and ideas from Harvard Business Review and HBR.org. Any opinions expressed are not endorsed by Reuters.

  • Ahead of the Bell: Alzheimer's update in the works Monday, 8 Oct 2012 | 6:41 AM ET

    Scientists will give pharmaceutical investors long-awaited updates Monday on research behind potential Alzheimer's disease treatments from Eli Lilly and Co., Pfizer Inc. and Johnson& Johnson.

  • Progress Software CEO resigns; warns on 4Q revenue Monday, 8 Oct 2012 | 12:14 AM ET

    BEDFORD, Mass.-- Progress Software Corp. said Monday that Jay Bhatt, its president, CEO and board member, is resigning to lead another software firm. Progress shares fell $2.81, or 13.1 percent, to $18.67 by midday, with more than three times the typical number of shares changing hands.

  • *Most news cases in Michigan. The widening outbreak has alarmed U.S. health officials and focused attention on regulations of pharmaceutical compounding companies like the one that produced the drugs, the New England Compounding Center Inc in Framingham, Massachusetts.

  • *Only 2 points behind in Reuters/ Ipsos poll. PORT ST. LUCIE, Fla., Oct 7- Mitt Romney appeared on Sunday to have halted his perilous slide in the polls and is back to running a close race with President Barack Obama as he prepares a new assault on the Democrat over foreign policy.

  • *Most news cases in Michigan. The widening outbreak has alarmed U.S. health officials and focused attention on regulations of pharmaceutical compounding companies like the one that produced the drugs, the New England Compounding Center Inc in Framingham, Massachusetts.

  • Most of the new cases were reported in Michigan, where the total increased to 20 from five. The widening outbreak has alarmed health officials across the United States and focused attention on regulations of pharmaceutical compounding companies like the one that produced the drugs, the New England Compounding Center Inc in Framingham, Massachusetts.

  • The cases have been traced to three lots of the steroid prepared by a pharmaceutical compounding plant in Massachusetts, New England Compounding Center Inc.. So far, cases of people becoming ill after receiving the steroid injections have been reported in Florida, Indiana, Maryland, Michigan, Minnesota, North Carolina, Ohio, Tennessee and Virginia.

  • *Ohio and Minnesota latest to report cases. The latest two deaths were reported on Saturday in Michigan, according to the U.S. Centers for Disease Control and Prevention. Other states with reported cases of people who fell ill after receiving the injections- primarily for back pain- are Michigan, Tennessee, Virginia, Florida, Maryland, North Carolina and Indiana.

  • NASHVILLE, Tenn., Oct 6- A widening outbreak of fungal meningitis has spread to Minnesota, which reported two cases to become the eighth U.S. state affected, officials said on Saturday.

  • Crisis highlights running dispute over US fish law Saturday, 6 Oct 2012 | 11:53 AM ET

    BOSTON-- The law that governs the nation's fisheries was passed 36 years ago to oust foreign boats working in U.S. waters. The law has become "an impediment to keeping the fishing industry alive," said Scituate fisherman Frank Mirachi.

  • Other states with cases are Tennessee, Virginia, Florida, Maryland, North Carolina and Indiana. The U.S. Centers for Disease Control reported 47 cases of meningitis on Friday, while Michigan reported an additional two cases and North Carolina one not included in the CDC count.